Bernard Coulie, President and CEO: Pliant Therapeutics PLRX Sell · Filed 23/01/25

Trade details

Type: Insider sale
Amount: $525,000
Shares · price: 15,000 sh · $35.00 a share
Held after: 434,317 sh
Stock: Pliant Therapeutics PLRX
Person: Bernard CouliePresident and CEO
Trade date: 23/01/23
Filed: 23/01/25
Days to filing: 2 days

Sold 3.3% of holdings

Share of holding sold: 3.3%

Pliant Therapeutics trades, last 26 weeks

What else happened in Pliant Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/24~23/02/22

Bernard Coulie's recent trades

Bernard CouliePresident and CEO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$114.4K
89,375 sh
$114.4K
Filed 01/22
Traded 01/20
Bernard CouliePresident and CEO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$587.1K
52,419 sh
$587.1K
Filed 25/01/22
Traded 25/01/17
Bernard CouliePresident and CEO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$447.5K
38,710 sh
$447.5K
Filed 24/07/12
Traded 24/07/10
Bernard CouliePresident and CEO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$443.2K
25,721 sh
$443.2K
Filed 24/01/19
Traded 24/01/17
Bernard CouliePresident and CEO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$1.3M
70,150 sh
$1.3M
Filed 23/07/19
Traded 23/07/17

Bernard Coulie, CEO — sold $525K of Pliant Therapeutics PLRX · 3.3% of holdings | Whalegun